Document is current

Any future updates will be listed below

SGLT2-Inhibitoren – ein Meilenstein in der Therapie des Typ-2-Diabetes

Crossref DOI link: https://doi.org/10.1007/s11560-020-00449-z

Published Online: 2020-07-20

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark